|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
18,391,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Phoenix Biotech Acquisition is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rapaport Robyn |
Director |
|
2024-02-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
Corey Daniel |
Chief Technical OfficerOfficer |
|
2024-02-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
683,015 |
|
- |
|
Geffken Daniel E |
Chief Financial Officer |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,002 |
10,002 |
|
- |
|
Kosacz Barbara |
Director |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,828 |
5,828 |
|
- |
|
Ehrlich Christopher B |
Director |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
3,600 |
3,600 |
|
- |
|
Ehrlich Christopher B |
Director |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
478,825 |
478,825 |
|
- |
|
Ehrlich Christopher B |
Director |
|
2024-02-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,296,246) |
1,000,000 |
|
- |
|
Phoenix Biotech Sponsor, Llc |
10% Owner |
|
2024-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,296,246) |
1,000,000 |
|
- |
|
Atwood Brian G |
Chief Executive Officer |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
248,735 |
248,735 |
|
- |
|
Atwood Brian G |
Chief Executive Officer |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
125,000 |
|
- |
|
Fisher Douglas |
President |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
43,300 |
43,300 |
|
- |
|
Loewy Caroline M |
Director |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,828 |
5,828 |
|
- |
|
Laporte Kathleen |
Director |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,828 |
5,828 |
|
- |
|
Phoenix Biotech Sponsor, Llc |
10% Owner |
|
2021-10-08 |
4 |
A |
$10.00 |
$367,330 |
D/D |
36,733 |
699,996 |
|
- |
|
Ehrlich Christopher B |
CEO and Secretary |
|
2021-10-08 |
4 |
A |
$10.00 |
$367,330 |
I/I |
36,733 |
699,996 |
|
- |
|
Fisher Douglas |
President |
|
2021-10-08 |
4 |
A |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
|
- |
|
Phoenix Biotech Sponsor, Llc |
10% Owner |
|
2021-10-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
663,263 |
|
- |
|
Ehrlich Christopher B |
CEO and and SecretaryOfficer |
|
2021-10-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
663,263 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
|